Stada Arzneimittel AG (SAZ):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Stada Arzneimittel AG (SAZ) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7190
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:41
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Stada Arzneimittel AG (STADA) is a manufacturer of low-cost generics and branded over the counter products. The company develops and markets drugs with off-patent active pharmaceutical ingredients, particularly, which are free from commercial property rights. It offers a portfolio of products in various therapeutic categories including pain, women’s health, cardiovascular conditions and diabetes. Few of its major generic products include including Tilidin Naloxon, Atorvastatin, Pantoprazol, Epoetin zeta and Diclofenac. Its major branded products include APO-Go, Grippostad, Snup, Fultium, and Vitaprost. The company operates in more than 30 countries with sales in Germany, Central Europe, CIS/Eastern Europe and Asia-Pacific. STADA is headquartered in Bad Vilbel, Germany.

Stada Arzneimittel AG (SAZ) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Stada Arzneimittel AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Stada Arzneimittel AG, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Stada Arzneimittel AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Stada Arzneimittel AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Stada Arzneimittel AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Stada Arzneimittel AG, Medical Equipment, Deal Details 10
Private Equity 10
Bain Capital and Cinven Partners to Acquire Stada Arzneimittel 10
Partnerships 12
3M Enters Into Licensing Agreement With Stada For Fentanyl Transdermal Patch Technology 12
Lophius Biosciences Enters into Agreement with BL&H 13
Vigilant Biosciences Enters into Distribution Agreement with BL&H 14
Acquisition 15
Nidda Healthcare to Acquire Stake in Stada Arzneimittel 15
STADA Arzneimittel Acquires SCIOTEC Diagnostic Technologies for USD19.8 Million 16
Stada Arzneimittel AG – Key Competitors 17
Stada Arzneimittel AG – Key Employees 18
Stada Arzneimittel AG – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 22
Financial Announcements 22
Aug 09, 2018: STADA’s business development in the first six months of 2018 as expected 22
May 03, 2018: STADA with solid business development in the first quarter of 2018 24
Mar 08, 2018: STADA records positive business development in 2017 26
Nov 09, 2017: STADA shows good business development in the third quarter of 2017 and the first nine months 29
Corporate Communications 31
Sep 03, 2018: Peter Goldschmidt to succeed Claudio Albrecht as STADA’s CEO 31
Apr 16, 2018: Changes in the management team of STADA 32
Feb 01, 2018: Supervisory Board of STADA Arzneimittel appoints Peter Goldschmidt as new Chairman of the Executive Board as of September 1, 2018 33
Feb 01, 2018: Peter Goldschmidt to succeed Claudio Albrecht as CEO on 1 September 2018 34
Jul 04, 2017: STADA Arzneimittel appoints new Chief Executive Officer and Chief Financial Officer – incumbents step down from their positions 35
Apr 24, 2017: Dr. Ralph Grobecker to become Managing Director of STADA’s OTC segment 36
Other Significant Developments 37
Sep 12, 2018: STADA invites the holders of the STADA Bond to participate in the bondholders meeting and to vote in favor of the proposed resolutions 37
Aug 03, 2017: STADA shows good operational development in first six months of 2017 38
Appendix 41
Methodology 41
About GlobalData 41
Contact Us 41
Disclaimer 41

List of Tables
Stada Arzneimittel AG, Medical Equipment, Key Facts, 2017 2
Stada Arzneimittel AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Stada Arzneimittel AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Stada Arzneimittel AG, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Stada Arzneimittel AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Stada Arzneimittel AG, Deals By Market, 2012 to YTD 2018 8
Stada Arzneimittel AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Bain Capital and Cinven Partners to Acquire Stada Arzneimittel 10
3M Enters Into Licensing Agreement With Stada For Fentanyl Transdermal Patch Technology 12
Lophius Biosciences Enters into Agreement with BL&H 13
Vigilant Biosciences Enters into Distribution Agreement with BL&H 14
Nidda Healthcare to Acquire Stake in Stada Arzneimittel 15
STADA Arzneimittel Acquires SCIOTEC Diagnostic Technologies for USD19.8 Million 16
Stada Arzneimittel AG, Key Competitors 17
Stada Arzneimittel AG, Key Employees 18
Stada Arzneimittel AG, Subsidiaries 19

List of Figures
Stada Arzneimittel AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Stada Arzneimittel AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Stada Arzneimittel AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Stada Arzneimittel AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Stada Arzneimittel AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Stada Arzneimittel AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Stada Arzneimittel AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Stada Arzneimittel AG, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Stada Arzneimittel AG (SAZ):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • J. Lauritzen AS:石油・ガス:M&Aディール及び事業提携情報
    Summary J. Lauritzen AS (J. Lauritzen), a subsidiary of Lauritzen Fonden, is a shipping company that provides ocean transport services. The company operates a fleet of bulk carriers and gas carriers. Its bulk carriers include ocean transport services for dry bulk cargoes. J. Lauritzen provides marit …
  • Northbridge Financial Corporation:企業の戦略的SWOT分析
    Northbridge Financial Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Cumberland Pharmaceuticals Inc (CPIX)-製薬・医療分野:企業M&A・提携分析
    Summary Cumberland Pharmaceuticals Inc (Cumberland Pharma) is a pharmaceutical company which develops and commercializes branded prescription products. The company’s product portfolio includes acetylcysteine, ibuprofen, lactulose, conivaptan, amifostine and ifetroban. It provides prescription produc …
  • Coherex Medical Inc-医療機器分野:企業M&A・提携分析
    Summary Coherex Medical Inc (Coherex), formerly Proximare, Inc is a subsidiary of Johnson & Johnson is a medical device company that designs, develops and markets catheter-based technologies for the treatment of certain structural heart defects. The company provides treatment of cardiovascular disea …
  • Xintela AB (XINT):企業の財務・戦略的SWOT分析
    Summary Xintela AB (Xintela) is a biomedical company that develops treatment for cartilage damage and brain tumors. The company’s technology includes Xinmark, a patented marker technology developed to identify and select certain types of tumor cells, which can develop into cartilage cells. It also o …
  • The Miyazaki Taiyo Bank, Ltd.:企業の戦略・SWOT・財務情報
    The Miyazaki Taiyo Bank, Ltd. - Strategy, SWOT and Corporate Finance Report Summary The Miyazaki Taiyo Bank, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Triumph Group Inc:戦略・SWOT・企業財務分析
    Triumph Group Inc - Strategy, SWOT and Corporate Finance Report Summary Triumph Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Beckman Coulter Inc:医療機器:M&Aディール及び事業提携情報
    Summary Beckman Coulter Inc (Beckman), is a subsidiary of Danaher Corp, is a manufacturer of biomedical testing instrument systems. It develops, manufactures and markets biomedical laboratory instruments, software and other things that simplify and automate complex biomedical tests. The company offe …
  • DSW Inc.:企業の戦略・SWOT・財務情報
    DSW Inc. - Strategy, SWOT and Corporate Finance Report Summary DSW Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • NOW Inc (DNOW):企業の財務・戦略的SWOT分析
    NOW Inc (DNOW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Delaware North Companies Inc:企業の戦略的SWOT分析
    Delaware North Companies Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Uranium Energy Corp:企業の戦略・SWOT・財務情報
    Uranium Energy Corp - Strategy, SWOT and Corporate Finance Report Summary Uranium Energy Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Emerald Health Sciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Emerald Health Sciences Inc (EHS) focuses to advance the development of cannabis in pharmaceutical, botanical and bioceutical applications. The company is developing EHP-101 based on cannabidiol for the treatment of multiple sclerosis (MS) and scleroderma; and EHP-102, derived from cannabige …
  • Esperion Therapeutics Inc (ESPR):企業の財務・戦略的SWOT分析
    Summary Esperion Therapeutics Inc (Esperion), a subsidiary of Pfizer Inc is a pharmaceutical company that develops and commercializes once-daily, oral and low-density lipoprotein cholesterol lowering therapies. The company develops oral therapies to treat patients with elevated low-density lipoprote …
  • Innergex Renewable Energy Inc (INE)-エネルギー分野:企業M&A・提携分析
    Summary Innergex Renewable Energy Inc. (Innergex) is an electricity services company that develops, owns, and operates renewable power-generating facilities. It sells electricity that is generated from hydro, wind, and solar sources. The company sells electricity through long-term power purchase agr …
  • Deltex Medical Group Plc (DEMG):企業の財務・戦略的SWOT分析
    Summary Deltex Medical Group Plc (Deltex Medical), formerly Chalkgrove Plc, is a medical device company that develops fluid management equipment and oesophageal doppler monitoring systems. The company offers products such as cardioQ-ODM+, probes, simulator, bougies, cerebral oximetry, video laryngos …
  • Recordati Rare Diseases Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Recordati Rare Diseases Inc (RRD), a subsidiary of Recordati SpA is a biopharmaceutical company that discovers and develops orphan drugs and biologics. The company’s products comprise chemet, neoprofen, panhematin, desoxyn, mustargen, carbaglu, cosmegen, peganone and tranxene, among others. …
  • MI Bioresearch Inc-医療機器分野:企業M&A・提携分析
    Summary MI Bioresearch Inc (MI), formerly Molecular Imaging Inc is a research institute that offers pharmacology research services. The institute offers services such as oncology pharmacology, immuno oncology, in vitro services, imaging and radiation. Its oncology pharmacology include subcutaneous m …
  • Lansdowne Oil & Gas plc (LOGP):企業の財務・戦略的SWOT分析
    Summary Lansdowne Oil & Gas Plc (Lansdowne Oil & Gas) is an independent oil and gas exploration and production company. The company acquires, explores and develops crude oil and natural gas appraisals in the North Celtic Sea Basin offshore in southern Ireland. It develops Barryroe Field in the North …
  • Nuclear Decommissioning Authority:企業の戦略的SWOT分析
    Nuclear Decommissioning Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆